Penetration of newer quinolones in the empyema fluid

European Respiratory Journal

Volumn 24, Issue 3, 2004, Pages 466-470

  Liapakis, I E ^a,b   Kottakis, I ^a   Tzatzarakis, M N ^c   Tsatsakis, A M ^c   Pitiakoudis, M S ^a   Ypsilantis, P ^a   Light, R ^b   Simopoulos, C E ^a   Bouros, D E ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

Chromatography; Escherichia coli; Levofloxacin; Moxifloxacin; Plural empyema; Turpentine

Indexed keywords

LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TURPENTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG INFUSION; DRUG PENETRATION; ESCHERICHIA COLI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLEURA CAVITY; PLEURA EMPYEMA; PLEURA FLUID; PRIORITY JOURNAL; RABBIT; THORACOCENTESIS; TIME;

ANIMALS; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; EMPYEMA, PLEURAL; ESCHERICHIA COLI INFECTIONS; MALE; OFLOXACIN; PLEURAL EFFUSION; QUINOLINES; RABBITS;

EID: 4544257939     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00007804     Document Type: Article

References (29)

1. Light RW, Girard WM, Jenkinson SG. The incidence and significance of parapneumonic effusions. Am J Med 1980; 69: 507-512.
2. Bouros D, Hamm H. Infectious pleural effusions. In: Loddenkemper R, Antony VB, eds. Pleural Diseases. Eur Respir Monograph 2002; 22: 204-218.
3. Sasse S, Nguyen T, Teixeira LR, Light RW. The utility of daily therapeutic thoracentecis for the treatment of early empyema. Chest 1999; 116: 1703-1708.
4. Sasse S, Nguyen T, Mulligan M, Nai-San W, Mahutte K, Light RW. The effects of early chest tube placement on empyema resolution. Chest 1997; 111: 1679-1683.
5. Bouros D, Schiza S, Siafakas N. Fibrinolytics in the treatment of parapneumonic effusions. Monaldi Arch Chest Dis 1999; 54: 258-263.
6. Zhanel GG, Ennis K, Vercaigne L, et al. A critical review of the fluoroquinolones: focus on respiratory infections. Drugs 2002; 62: 13-59.
7. Detache CJ, Dewan N, O'Donahue WJ, et al. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis. J Antimicrob Chemother 1999; 43: Suppl., 107-113.
8. Siegel RE. Strategies for early discharge of the hospitalized patient with community-acquired pneumonia. Clin Chest Med 1999; 20: 599-605.
9. Palmer CS, Zhan C, Elixhauser A, et al. Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacin. Clin Ther 2000; 22: 250-264.
10. Davies BI, Maesen FP. Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity. J Antimicrob Chemother 1999; 43: Suppl., 83-90.
11. Byl B, Jacobs F, Roucloux I, De Franquen P, Cappello M, Thys J-P. Penetration of meropenem in lung, bronchial mucosa and pleural tissues. Antimicrob Agents Chemother 1999; 43: 681-682.
12. Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J 1997; 10: 1150-1156.
13. Liapakis IE, Kottakis I, Light RW, Bouros D. Pharmacokinetics and pharmacodynamics in the pleural space. In: Bouros D, ed. Pleural Diseases. New York, Dekker 2004; pp 999-1008.
14. Teixeira LR, Sasse SA, Villarino MA, Nguyen T, Mulligan ME, Light RW. Antibiotic levels in empyemic pleural fluid. Chest 2000; 117: 1734-1739.
15. Sasse S, Causing L, Mulligan M. Serial pleural fluid analysis in a new experimental model of empyema. Chest 1996; 109: 1043-1048.
16. Sahn SA, Potts DE. Turpentine pleurisy in rabbits: a model of pleural fluid acidosis and low pleural fluid glucose. Am Rev Respir Dis 1978; 118: 893-901.
17. Chandler TM, McCoskey EH, Byrd RP Jr, Roy TM. Comparison of the use and accuracy of methods for determining pleural fluid pH. South Med J 1999; 92: 214-217.
18. Bottcher S, Baum HV, Hoppe-Tichy T, Benz C, Sonntag HG. An HPLC assay and a microbiologioal assay to determine levofloxacin in soft tissue, bone, bile and serum. J Pharm Biomed Analysis 2001; 25: 197-203.
19. Lemoine T, Breilh D, Ducint D, et al. Determination of moxifloxacin (BAY 12-8039) in plasma and lung tissue by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method with a new polymeric cartridge. J Chromatography B 2000; 742: 247-254.
20. Tsatsakis AM, Alegakis TK, Chalkiadakis GE, Askoxilakis I, Vlachonikolis I. Comparative pharmacokinetics of ceftriaxone after periincisional and intravenous administration in patients undergoing abdominal surgery. Eur J Pharm S 1997; 5: 243-251.
21. Neckel U, Joukhadar C, Frossard M, Jager M, Muller M, Mayer BX. Simultaneous determination of levofloxacin and ciprofloxacin in microdialysates and plasma by high-performance liquid chromatography. Analytica Chimica Acta 2002; 463: 199-206.
22. Strahilevitz J, Lev A, Levi I, Fridman E, Rubinstein E. Experimental pneumococcal pleural empyema model: the effect of moxifloxacin. J Antimicrob Chemother 2003; 51: 665-669.
23. Schentag JJ, Gilliland KK, Paladino JA. What have we learned from the pharmacokinetic and pharmacodynamic theories? Clin Inf Dis 2001; 32: Suppl. 1, S39-S46.
24. Mouton JW, Dudley MN, Cars O, Derendorf H, Drusano GL. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs. Int J Antimicrob Agents 2002; 19: 355-358.
25. Zhanel GG, Ennis K, Vercaigne L, et al. A critical review of the fluoroquinolones. Focus on respiratory tract infections. Drugs 2002; 62: 13-59.
26. Taryle DA, Good JT Jr, Morgan EJ III, et al. Antibiotic concentrations in human parapneumonic effusions. J Antimicrob Chemother 1981; 7: 171-177.
27. Thys JP, Vanderhoeft P, Herchuelz A, et al. Penetration of aminoglycosides in uninfected pleural exudates and in pleural empyemas. Chest 1988; 93: 530-532.
28. Sakuma T, Kubo H, Tanita T, Koike K, Fujimura S. Penetration of intravenous antibiotics from the lung into the pleural space after pulmonary resection. J Thorac Cardiovasc Surg 1994; 107: 955-957.
29. Light RW. Pleural diseases, 4th Edn. Baltimore, MD, Williams and Wilkins, 2001; pp. 1-6.